Results of interim analysis of a retrospective IGIBD study on adalimumab use in real practice in Italy: the REAL-life clinical effectiveness of ADAlimumab in ulcerative colitis

被引：0
|
作者：
Pugliese, D. [1 ]
Mendolaro, M. [2 ]
D'Inca, R. [3 ]
Ribaldone, D. G. [4 ]
Principi, M. [5 ]
Ricci, C. [6 ]
Stasi, E. [7 ]
Scribano, M. L. [8 ]
Bodini, G. [9 ]
Saibeni, S. [10 ]
Privitera, A. C. [11 ]
Simondi, D. [12 ]
Armuzzi, A. [1 ]
Daperno, M. [2 ]
机构：
[1] Fdn Policlin Gemelli IRCCS, Gastroenterol, Rome, Italy
[2] Mauriziano Hosp, Gastroenterol Unit, Turin, Italy
[3] Univ Padua, Gastroenterol Unit, Padua, Italy
[4] Citta Sci & Salute, Gastroenterol Unit, Turin, Italy
[5] Bari Univ, Gastroenterol Unit, Bari, Italy
[6] Spedali Civil Brescia, Internal Med, Brescia, Italy
[7] IRCCS De Bellis, Gastroenterol Unit, Castellana Grotte, Italy
[8] S Camillo Forlanini Hosp, Gastroenterol Unit, Rome, Italy
[9] Genova Univ Hosp, Gastroenterol Unit, Genoa, Italy
[10] Rho Hosp, Gastroenterol Unit, Rho, Italy
[11] Cannizzaro Hosp, Gastroenterol Unit, Catania, Italy
[12] S Croce & Carle Hosp, Gastroenterol Unit, Cuneo, Italy
来源：
JOURNAL OF CROHNS & COLITIS | 2019年 / 13卷
关键词：
D O I：
10.1093/ecco-jcc/jjy222.636
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P512
引用
收藏
页码：S369 / S369
页数：1
相关论文
共 50 条
  • [41] Adalimumab (HUMIRA®) is effective and safe in treating psoriatic arthritis (PsA) in real-life clinical practice:: Preliminary results of the STEREO trial.
    Van den Bosch, F.
    Reece, R.
    Manger, B.
    Goupille, P.
    Roedevand, E.
    Holck, P.
    FitzGerald, O.
    Van Vollenhoven, R.
    Leirisalo-Repo, M.
    Kron, M.
    Frank, M.
    Kupper, H.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S719 - S720
  • [42] Treatment with adalimumab (Humira®) is safe and effective in psoriatic arthritis (PsA) patients in real-life clinical practice:: Preliminary results of the stereo trial
    Vandenbosch, F.
    McHugh, N. J.
    Reece, R.
    Cooper, R.
    Manger, B.
    Goupille, P.
    FitzGerald, O.
    Kron, M.
    Frank, M.
    Kupper, H.
    Roedevand, E.
    Holck, P.
    VanVollenhoven, R.
    Leirisalo-Repo, M.
    RHEUMATOLOGY, 2007, 46 : I52 - I53
  • [43] Effectiveness and patterns of bortezomib use in real-life practice: Results of VESUVE, a French cohort study
    Fourrier-Reglat, A.
    Eghbali, H.
    Facon, T.
    Fermand, J.
    Fitoussi, O.
    Marit, G.
    Grelaud, A.
    Bignon, E.
    Jove, J.
    Moore, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [44] Vortioxetine in routine clinical practice: results from the real-life effectiveness of vortioxetine (RELIEVE) study
    Mattingly, G.
    Ren, H.
    Christensen, M. Cronquist
    Simonsen, K.
    Hammer-Helmich, L.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 53 : S529 - S530
  • [45] Effectiveness and pattern of bortezomib use in real-life practice: results of VESUVE, a French cohort study
    Fourrier-Reglat, A.
    Thomare, P.
    Grelaud, A.
    Bignon, E.
    Jove, J.
    Moore, N.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2010, 24 : 35 - 35
  • [46] Impact of adalimumab in patients with active non-infectious intermediate, posterior, and panuveitis in real-life clinical practice: HOPE study
    Pleyer, Uwe
    Al-Mutairi, Salem
    Murphy, Conor C.
    Hamam, Rola
    Hammad, Shereen
    Nagy, Orsolya
    Szepessy, Zsuzsanna
    Guex-Crosier, Yan
    Julian, Karina
    Habot-Wilner, Zohar
    Androudi, Sofia
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2023, 107 (12) : 1892 - 1899
  • [47] Adalimumab (HUMIRA®) is effective and safe in treating rheumatoid arthritis (RA) in real-life clinical practice:: 1-year-results of the ReAct study.
    Burmester, GR
    Sáez, IM
    Malaise, MG
    Kary, S
    Kupper, H
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S541 - S542
  • [48] Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy
    Tarsi, Antonio
    Mocci, Giammarco
    Cuomo, Antonio
    Ferronato, Antonio
    Elisei, Walter
    Picchio, Marcello
    Maconi, Giovanni
    Scaldaferri, Franco
    Papa, Alfredo
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2022, 31 (04) : 411 - 416
  • [49] Use of adalimumab biosimilar ABP 501 in Crohn's disease: A real-life experience
    Ribaldone, D. G.
    Vernero, M.
    Pellicano, R.
    Morino, M.
    Saracco, G. M.
    Astegiano, M.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S510 - S511
  • [50] Adalimumab use in Paediatric Inflammatory Bowel Disease: A single centre real-life experience
    El-Lababidi, N.
    Fruhauf, P.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I531 - I532
12345